Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
May 27, 1994
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin
M F Stevens, C J McCall, P Lelieveld, et al.
Biochimie
|
August 1, 1987
Structure-activity relationships of sparsomycin: modification at the hydroxyl group
E Lázaro, L A van den Broek, H C Ottenheijm, et al.
Oncology
|
January 1, 1987
Reduction of cis-dichlorodiammineplatinum(II) caused nephrotoxicity by indazolone carboxylic acid
M Radacić, M Boranić, D Skarić, et al.
Anti-Cancer Drug Design
|
December 1, 1987
Novel bioreductive mitosene and mitosane analogues of mitomycin C
W Verboom, D N Reinhoudt, B H Lammerink, et al.
Journal of Medicinal Chemistry
|
August 16, 1996
Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo
D F Shi, T D Bradshaw, S Wrigley, et al.
Anticancer Research
|
January 1, 1994
In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells
B J Braakhuis, B T Hill, M Dietel, et al.
Anticancer Research
|
July 1, 1986
Electrochemistry of potential bioreductive alkylating quinones: its use in the development of new aziridinylquinones
R J Driebergen, J J Holthuis, A Hulshoff, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1984
Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivatives
P Lelieveld, W J Van der Vijgh, R W Veldhuizen, et al.
Journal of Medicinal Chemistry
|
February 1, 1987
Structure-activity relationships of sparsomycin and its analogues. Inhibition of peptide bond formation in cell-free systems and of L1210 and bacterial cell growth
L A van den Broek, R M Liskamp, J H Colstee, et al.
Investigational New Drugs
|
December 1, 1988
In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor models
Z Zylicz, D J Wagener, H van Rennes, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
May 27, 1994
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin
M F Stevens, C J McCall, P Lelieveld, et al.
Biochimie
|
August 1, 1987
Structure-activity relationships of sparsomycin: modification at the hydroxyl group
E Lázaro, L A van den Broek, H C Ottenheijm, et al.
Oncology
|
January 1, 1987
Reduction of cis-dichlorodiammineplatinum(II) caused nephrotoxicity by indazolone carboxylic acid
M Radacić, M Boranić, D Skarić, et al.
Anti-Cancer Drug Design
|
December 1, 1987
Novel bioreductive mitosene and mitosane analogues of mitomycin C
W Verboom, D N Reinhoudt, B H Lammerink, et al.
Journal of Medicinal Chemistry
|
August 16, 1996
Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo
D F Shi, T D Bradshaw, S Wrigley, et al.
Anticancer Research
|
January 1, 1994
In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells
B J Braakhuis, B T Hill, M Dietel, et al.
Anticancer Research
|
July 1, 1986
Electrochemistry of potential bioreductive alkylating quinones: its use in the development of new aziridinylquinones
R J Driebergen, J J Holthuis, A Hulshoff, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1984
Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivatives
P Lelieveld, W J Van der Vijgh, R W Veldhuizen, et al.
Journal of Medicinal Chemistry
|
February 1, 1987
Structure-activity relationships of sparsomycin and its analogues. Inhibition of peptide bond formation in cell-free systems and of L1210 and bacterial cell growth
L A van den Broek, R M Liskamp, J H Colstee, et al.
Investigational New Drugs
|
December 1, 1988
In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor models
Z Zylicz, D J Wagener, H van Rennes, et al.
Page
of 5